Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal

摘要

The present invention relates to a combination product comprising at least one nucleic acid containing a sequence encoding a polypeptide or interest and at least one phospholipid of interest, for use which is simultaneous, consecutive or spread out over time, characterized in that said polypeptide and phospholipid of interest have cytotoxic activity.